The Valley Desk

NCT05014139 · Interventional trial

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Overall registry status Terminated

Phase 1

Conditions Carcinoma Transitional Cell, Carcinoma in Situ, NMIBC, Non-muscle Invasive Bladder Cancer, Urinary Bladder Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov